The transition to a resilient, responsive, sustainable high-value health care system necessitates innovation in some of the key critical components in the system.

This may include interoperable and integrated digital data systems with real time analytics and performance benchmarking, structured measurement of costs and outcomes, systems for risk stratification, bundled health care services, integrated care pathways, value-based procurement and payment models, and an ecosystem for innovation. Lastly, adoption and cross-learning, along with behavioral and strategic changes among payers and providers, is also much needed.

In order to partake in this transition, MedTech must also make a transition to context sensitive innovations from generalized solutions, and boutique cases to strategic investment-based tactical projects. Building on the insights from his 2021 book “Building a High-Value Health System”4, Professor Atun described ten essential steps that MedTech can follow as a change maker to facilitate strategic public-private partnerships (Table 1).

In these approaches, MedTech can enter risk-sharing partnerships with providers or payers that improve patient outcomes while lowering the cost of delivering those outcomes, ranging from the treatment level to population management of diseases.

The COVID-19 pandemic has exposed the underperformance of health care systems with regards to effectiveness, equity, responsiveness and efficiency.

There is a need, now more than ever, for health care to move towards a high-value and innovative health system starting at the therapy, single disease, multiple disease bundle or population level with temporal bundling.